Apoorva et al found that aspirin prevents doxorubicin-induced repression of SMAR1 (scaffold matrix attachment region binding protein 1) and proliferation of breast cancer stem-like cells, consequently enhancing the cytotoxicity of doxorubicin (23). The gene discussed is BANP; the disease is breast cancer.